Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - IMMUNOMEDICS INC | immu-20170630ex3222e676e.htm |
| EX-32.1 - EX-32.1 - IMMUNOMEDICS INC | immu-20170630ex32114ec3d.htm |
| EX-31.2 - EX-31.2 - IMMUNOMEDICS INC | immu-20170630ex312146a47.htm |
| EX-31.1 - EX-31.1 - IMMUNOMEDICS INC | immu-20170630ex31130c459.htm |
| EX-23.1 - EX-23.1 - IMMUNOMEDICS INC | immu-20170630ex2311dfb26.htm |
| EX-10.37 - EX-10.37 - IMMUNOMEDICS INC | immu-20170630ex103752071.htm |
| 10-K - 10-K - IMMUNOMEDICS INC | immu-20170630x10k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE COMPANY AS OF JUNE 30, 2017
|
● |
Immunomedics, B.V. (Netherlands) |
Wholly owned subsidiary of Immunomedics, Inc. |
|
|
|
|
|
|
|
|
|
● |
Immunomedics GmbH (Germany) |
Wholly owned subsidiary of Immunomedics, Inc. |
|
|
|
|
|
|
|
|
|
● |
IBC Pharmaceuticals, Inc. (Delaware) |
Majority owned subsidiary of Immunomedics, Inc. |